1. Home
  2. QMCO vs IMRN Comparison

QMCO vs IMRN Comparison

Compare QMCO & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum Corporation

QMCO

Quantum Corporation

N/A

Current Price

$7.19

Market Cap

157.2M

Sector

Technology

ML Signal

N/A

Logo Immuron Limited

IMRN

Immuron Limited

N/A

Current Price

$0.91

Market Cap

12.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QMCO
IMRN
Founded
1980
1994
Country
United States
Australia
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.2M
12.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
QMCO
IMRN
Price
$7.19
$0.91
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$16.50
N/A
AVG Volume (30 Days)
481.4K
1.3M
Earning Date
02-11-2026
08-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$256,949,000.00
$4,777,422.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.51
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.63
52 Week Low
$6.51
$0.91
52 Week High
$90.64
$2.48

Technical Indicators

Market Signals
Indicator
QMCO
IMRN
Relative Strength Index (RSI) 40.45 23.77
Support Level $7.07 $0.91
Resistance Level $7.88 $0.97
Average True Range (ATR) 0.66 0.06
MACD -0.12 -0.02
Stochastic Oscillator 7.00 0.00

Price Performance

Historical Comparison
QMCO
IMRN

About QMCO Quantum Corporation

Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data in the era of artificial intelligence (AI). It provides one of the comprehensive and cost-efficient solutions for the entire data lifecycle. The group provides solutions for video, images, audio, and other large files because this unstructured data represents. Its portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The group operates in three geographic regions: Americas, Europe, the Middle East, and Africa (EMEA), and Asia Pacific (APAC).

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

Share on Social Networks: